Vietnam Drug Administration Rejects Changes In Price Cap Rules
This article was originally published in PharmAsia News
Executive Summary
The Drug Administration of Vietnam told drug makers it has rejected their suggestions and will maintain current procedures controlling the prices of drugs. The companies had wanted the Health Ministry to drop its requirement that they present material invoices when they request price increases, and instead to base the price caps on marketing prices in the exporting country. The firms were told Vietnam intends to retain current policy of basing prices on cost, insurance and import transportation costs, the central factor drug makers want changed. Prices also are based on transportation and management costs, and on profit margins. (Click here for more
|
The Drug Administration of Vietnam told drug makers it has rejected their suggestions and will maintain current procedures controlling the prices of drugs. The companies had wanted the Health Ministry to drop its requirement that they present material invoices when they request price increases, and instead to base the price caps on marketing prices in the exporting country. The firms were told Vietnam intends to retain current policy of basing prices on cost, insurance and import transportation costs, the central factor drug makers want changed. Prices also are based on transportation and management costs, and on profit margins. (Click here for more) "Ministry Rejects Foreign Firms' Price Fixing Protocol" - Thanhnien News (Vietnam) (1/14/09) |